Article
Authorship
Schlaen, Bernardo Ariel
;
Montoya, Juliana
;
Heredia, Milagros
;
Ficoseco, Carla
;
DOMINGUEZ, LUCIA
Date
2022
Publishing House and Editing Place
Arhketypo
Magazine
AUTOINMUNIDAD,
vol. 5
(pp. 114-120)
- ISSN 2545-6032
Arhketypo
Arhketypo
ISSN
2545-6032
Summary
Information provided by the agent in
SIGEVA
Ocular cicatricial pemphigoid is a progressive, bilateral, chronic disease, of autoimmune etiology, in which autoantibody deposits are observed in mucosal basement membranes. It is regarded as a mucous membrane pemphigoid subtype, a bullous dermatitis, characterized by blistering in mucosal tissues of nose, mouth, respiratory tract, and genitalia. As a counterpart, ocular involvement without systemic manifestations is observed up to one third of the patients. Ophthalmological presentation is as...
Ocular cicatricial pemphigoid is a progressive, bilateral, chronic disease, of autoimmune etiology, in which autoantibody deposits are observed in mucosal basement membranes. It is regarded as a mucous membrane pemphigoid subtype, a bullous dermatitis, characterized by blistering in mucosal tissues of nose, mouth, respiratory tract, and genitalia. As a counterpart, ocular involvement without systemic manifestations is observed up to one third of the patients. Ophthalmological presentation is asymmetric, with a conjunctival inflammation which evolves to fibrosis, leading to an ocular surface insufficiency, and infectious and inflammatory complications, as well as a potentially devastating visual loss. A timely diagnosis, with an interdisciplinary approach and a suitable systemic treatment, are pivotal and they require a high level of experience, since this condition may be extremely difficult in identifying and treating.
Show more
Show less
Key Words
CONJUNTIVITISPENFIGOIDEINMUNOSUPRESORTRATAMIENTO
Download or request the full text